Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion

被引:33
|
作者
Giansante, C
Fiotti, N
Miccio, M
Altamura, N
Salvi, R
Guarnieri, G
机构
[1] Univ Trieste, Inst Clin Med, I-34149 Trieste, Italy
[2] Osped Maggiore, Emergency Unit, Trieste, Italy
关键词
D O I
10.1067/mhj.2000.108520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine whether paroxysmal atrial fibrillation (PAF) and/or restoration to sinus rhythm with electric or pharmacologic cardioversion induce modifications to the coagulation system. Thirty-five patients with PAF undergoing either electric (n = 11) or pharmacologic (n = 24) cardioversion were studied. Fibrinopeptide A and D-dimer blood samples were taken immediately before and after cardioversion at different intervals. When compared with the control group (n = 70), the precardioversion fibrinopeptide A plasma values were significantly elevated (11.8 vs 2.5 ng/ml). Fibrinopeptide A plasma values were significantly reduced 5 minutes after cardioversion (11.8 vs 5.3 ng/mL) and remained stable throughout the follow-up sequential measurements. D-dimer plasma values were significantly increased (measured at 12 hours and at day 7) in patients who underwent electrical cardioversions only. A positive correlation (R-2 = 0.76) was found between the energy delivered for cardioversion to sinus rhythm and D-dimer plasma values on day 7. in patients with PAF, levels of fibrinopeptide A, an indicator of coagulation activation, are elevated and soon reduced by the restoration of sinus rhythm. Electric, but not pharmacologic, cardioversion induces an early activation of the fibrinolytic system.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [1] Coagulation indicators in patients with paroxysmal atrial fibrillation: Effect of electrical and pharmacological cardioversion.
    Giansante, C
    Fiotti, N
    Miccio, M
    Calabrese, S
    Salvi, R
    Borri, A
    Guarnieri, G
    ATHEROSCLEROSIS, 1999, 145 : S19 - S19
  • [2] Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis
    Dimitris Tsiachris
    Ioannis Doundoulakis
    Eirini Pagkalidou
    Athanasios Kordalis
    Spyridon Deftereos
    Konstantinos A. Gatzoulis
    Konstantinos Tsioufis
    Christodoulos Stefanadis
    Cardiovascular Drugs and Therapy, 2021, 35 : 293 - 308
  • [3] Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis
    Tsiachris, Dimitris
    Doundoulakis, Ioannis
    Pagkalidou, Eirini
    Kordalis, Athanasios
    Deftereos, Spyridon
    Gatzoulis, Konstantinos A.
    Tsioufis, Konstantinos
    Stefanadis, Christodoulos
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (02) : 293 - 308
  • [4] Pharmacologic Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department in the Novel Anticoagulants’ Era
    Dimitris Tsiachris
    Ioannis Doundoulakis
    Konstantinos Tsioufis
    Cardiovascular Drugs and Therapy, 2022, 36 : 1253 - 1254
  • [5] Pharmacologic Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department in the Novel Anticoagulants' Era
    Tsiachris, Dimitris
    Doundoulakis, Ioannis
    Tsioufis, Konstantinos
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (06) : 1253 - 1254
  • [6] Pharmacologic cardioversion for atrial fibrillation and flutter
    Cayley, WE
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (11) : 2217 - 2219
  • [7] Electrical and Pharmacologic Cardioversion for Atrial Fibrillation
    Kim, Susan S.
    Knight, Bradley P.
    CARDIOLOGY CLINICS, 2009, 27 (01) : 95 - +
  • [8] Electrical and pharmacologic cardioversion for atrial fibrillation
    Kim, Susan S.
    Knight, Bradley P.
    MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 (01) : 101 - +
  • [9] Cardioversion of paroxysmal atrial fibrillation - Reply
    Michael, JA
    ANNALS OF EMERGENCY MEDICINE, 1999, 34 (05) : 687 - 688
  • [10] Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?
    Meaghan MacKenzie
    Dana Stewart
    Chris Hall
    Canadian Journal of Emergency Medicine, 2021, 23 : 32 - 33